What is the recommended dosing schedule for amitriptyline in depression, including starting dose, titration increments, maximum dose, and adjustments for elderly or patients with hepatic impairment?

Amitriptyline Dosing for Depression

For depression in adults, start amitriptyline at 75 mg daily in divided doses for outpatients (or 50-100 mg at bedtime as an alternative), titrate to 150 mg daily as needed, with hospitalized patients potentially requiring up to 200-300 mg daily; however, elderly patients should start at 10 mg three times daily with 20 mg at bedtime, with maximum doses rarely exceeding 100 mg daily. 1

Starting Doses

Adult Outpatients

• Standard approach: 75 mg daily in divided doses 1
• Alternative bedtime dosing: 50-100 mg at bedtime, which may offer superior efficacy compared to divided dosing 1, 2
• Increases should be made preferably in late afternoon and/or bedtime doses 1

Hospitalized Patients

• Start at 100 mg daily 1
• Can increase gradually to 200 mg daily if necessary 1
• A small subset may require up to 300 mg daily 1

Elderly and Adolescent Patients

• Start at 10 mg three times daily with 20 mg at bedtime 1
• This lower starting dose is critical due to increased intestinal transit time and decreased hepatic metabolism in elderly patients, resulting in higher plasma levels for any given dose 1
• Elderly patients experience significantly higher rates of cardiovascular adverse effects at standard doses, including orthostatic hypotension without compensatory heart rate increase, and impaired myocardial conduction 3

Titration Schedule

Standard Titration

• Initial dose can be increased to 150 mg daily for outpatients as needed 1
• When using bedtime dosing, increase by 25-50 mg increments to reach 150 mg daily 1
• Therapeutic effect may take up to 30 days to develop, though sedative effects appear earlier 1

Elderly Patients

• Maintain lower doses that are better tolerated 1
• Monitor carefully with quantitative serum levels as clinically appropriate 1
• Adjust based on clinical response, not plasma levels alone 1

Maximum Doses

• Outpatients: 150 mg daily (standard maximum) 1
• Hospitalized patients: 200 mg daily (up to 300 mg in select cases) 1
• Elderly/adolescents: Typically remain at lower doses; many tolerate only the starting regimen 1

Maintenance Dosing

• Usual maintenance: 50-100 mg daily 1
• Some patients adequately controlled on 40 mg daily 1
• Total daily dose may be given as a single dose, preferably at bedtime 1
• Continue maintenance therapy for at least 3 months to reduce relapse risk 1
• First episode depression should be treated for at least 4 months; recurrent depression may benefit from prolonged treatment 4

Special Populations and Adjustments

Hepatic Impairment

The FDA label notes that elderly patients have decreased hepatic metabolism, requiring careful monitoring and dose adjustments 1. While specific hepatic impairment dosing isn't explicitly provided, the elderly dosing recommendations (starting at 10 mg TID + 20 mg qHS) serve as a reasonable proxy for hepatic dysfunction.

Clinical Monitoring

• Plasma level monitoring is useful for identifying toxic levels or suspected non-compliance 1
• Wide variation exists in absorption and distribution, making direct plasma-therapeutic effect correlation difficult 1
• Elderly patients should have plasma levels checked as clinically appropriate due to higher levels at equivalent doses 1

Important Caveats

Efficacy Considerations

• Amitriptyline shows modest superiority over placebo (NNT 7-16 for TCAs) 4
• Antidepressants are most effective in severe depression 4
• A Cochrane review found amitriptyline at least as efficacious as other tricyclics and newer compounds, though with greater side effect burden 5
• Amitriptyline was more effective than control antidepressants in inpatients (NNT=24) but not outpatients 5

Common Pitfalls

• Underdosing is common in real-world practice: Studies show elderly patients often receive inadequate doses (average 49 mg/day, with many receiving only 10-30 mg/day) 6
• However, low-dose amitriptyline (10-30 mg) may still provide benefit in some patients, particularly for headache and other pain conditions 7
• Cardiovascular monitoring is essential in elderly patients: Significant ECG changes (increased PQ and QRS intervals) and orthostatic hypotension occur frequently 3

Side Effects

• 63% of patients experience at least one adverse effect 4
• Most common: anticholinergic effects (dry mouth, constipation), dizziness, fatigue 4
• Elderly patients are at higher risk: cardiovascular effects, falls, confusion 3
• Nausea and vomiting are the most common reasons for discontinuation 4
• Number needed to harm for discontinuation: 4-30 for TCAs vs 20-90 for SSRIs 4

Alternative Considerations

For elderly patients specifically, guidelines suggest that citalopram, escitalopram, sertraline, mirtazapine, venlafaxine, and bupropion are preferred agents due to better tolerability profiles 4. Amitriptyline should be reserved for cases where these agents have failed or are contraindicated.